Stockscreener 앱 받기
81.65
5.23%
-4.51
전일 마감가:
$86.16
열려 있는:
$86.16
하루 거래량:
80,923
Relative Volume:
1.23
시가총액:
$504.70M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-35.50
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
+0.50%
1개월 성능:
-17.85%
6개월 성능:
+81.61%
1년 성능:
+458.10%
1일 변동 폭
$77.00
$86.16
1주일 범위
$77.00
$89.86
52주 변동 폭
$13.94
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
명칭
Monopar Therapeutics Inc
전화
(847) 388-0349
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
81.80 | 531.60M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-09-09 | 개시 | BTIG Research | Buy |
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-08-26 | 재개 | H.C. Wainwright | Buy |
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-19 | 재개 | Piper Sandler | Overweight |
| 2025-01-10 | 개시 | Piper Sandler | Overweight |
| 2024-10-11 | 개시 | Rodman & Renshaw | Buy |
| 2021-01-28 | 개시 | ROTH Capital | Buy |
모두보기
Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스
What moving averages say about Monopar Therapeutics Inc.2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com
Is Monopar Therapeutics Inc. stock entering bullish territory2025 Analyst Calls & Real-Time Buy Zone Alerts - newser.com
Top chart patterns to watch in Monopar Therapeutics Inc.Market Risk Analysis & Low Volatility Stock Suggestions - newser.com
Monopar Therapeutics Inc. stock prediction for this weekQuarterly Market Review & Accurate Buy Signal Notifications - newser.com
Why Monopar Therapeutics Inc. stock attracts global investorsWeekly Trend Recap & Verified Short-Term Plans - newser.com
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingPortfolio Update Report & Expert Curated Trade Ideas - newser.com
Is Monopar Therapeutics Inc. stock attractive for retirement portfoliosWeekly Risk Report & Community Consensus Trade Signals - newser.com
Is Monopar Therapeutics Inc. forming a reversal patternQuarterly Portfolio Report & Target Return Focused Picks - newser.com
Has Monopar Therapeutics Inc. formed a bullish divergenceWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Why Monopar Therapeutics Inc. stock remains a top recommendationJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Will Monopar Therapeutics Inc. stock deliver long term returns2025 Sector Review & Risk Adjusted Buy/Sell Alerts - newser.com
Multi factor analysis applied to Monopar Therapeutics Inc.Wall Street Watch & Risk Managed Investment Signals - newser.com
Exit strategy if you’re trapped in Monopar Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Heatmap analysis for Monopar Therapeutics Inc. and competitorsJuly 2025 Decliners & Verified Swing Trading Watchlists - newser.com
When is the best time to exit Monopar Therapeutics Inc.Weekly Loss Report & High Return Stock Watch Alerts - newser.com
Applying sector rotation models to Monopar Therapeutics Inc.Watch List & Verified Technical Trade Signals - newser.com
Monopar Therapeutics Inc. (MNPR) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Monopar Therapeutics’ Innovative Imaging Agent Study: Market Implications - TipRanks
Monopar Therapeutics (MNPR) Price Target Increased by 14.64% to 113.81 - Nasdaq
How risky is Monopar Therapeutics Inc. (1IY0) stock compared to peersTrade Ideas & High Conviction Buy Zone Picks - fcp.pa.gov.br
Aug Closing: How Monopar Therapeutics Inc. (1IY0) stock benefits from digital adoptionJuly 2025 Action & Entry Point Confirmation Alerts - fcp.pa.gov.br
Monopar Therapeutics (FRA:1IY0) EV-to-EBIT : -21.79 (As of Oct. 27, 2025) - GuruFocus
Is Monopar Therapeutics Inc. stock attractive for income investorsJuly 2025 Trends & Growth Focused Stock Pick Reports - fcp.pa.gov.br
Monopar Therapeutics Inc (MNPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Monopar Therapeutics Inc 주식 (MNPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R | Director |
Jul 14 '25 |
Sale |
40.00 |
8,904 |
356,171 |
11,486 |
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
0.27%
0.10%
자본화:
|
볼륨(24시간):